Lipella Pharmaceuticals Inc. (LIPO) Operating cash flow 2021–2024
Lipella Pharmaceuticals Inc. (LIPO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.0MFY2024 · since FY2021: -$989,271 → -$4.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$4.0M | -25.4% |
| FY2023 | -$3.2M | -72.0% |
| FY2022 | -$1.8M | -85.1% |
| FY2021 | -$989,271 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LIPO financial trends
LIPO RevenueLIPO Net incomeLIPO Net marginLIPO Gross profitLIPO Gross marginLIPO Operating incomeLIPO Operating marginLIPO Free cash flowLIPO Capital expendituresLIPO Return on equityLIPO Stock buybacksLIPO Dividends paidLIPO Total assetsLIPO Total liabilitiesLIPO Shareholders’ equityLIPO overview →